Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,142

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,799

Class I recallsReasonable probability of serious health consequences

24,349

Class II recallsTemporary or medically reversible health consequences

2,891

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/fontanini-foods-llc-recalls-raw-frozen-pork-sausage-products-due-possible-foreignPublished September 25, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 28, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,349
Class I	9,799
Class III	2,891
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,349
Class I	9,799
Class III	2,891
Not Yet Classified	1

FDA Recall Terminated Historical recordClass III

Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada

by Valeant Pharmaceuticals North America LLC

Reason: Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset
Published: October 22, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTABLE IM USE. Manufactured by Avella Specialty Pharmacy, Phoenix, AZ 85085.

by Avella of Deer Valley, Inc.

Reason: Crystallization: Formation of crystals observed in product.
Published: October 22, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ USA 08534. NDC 68382-141-14.

by Zydus Pharmaceuticals USA Inc

Reason: Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.
Published: October 22, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

E-Z- GAS II EFFERVESCENT GRANULES Antacid/Antiflatulent ,4 g (0.14 oz), 50 -count box, Rx Only, Manufactured in USA for E-Z EM, Inc. Lake Success, NY 11042 by Tower Laboratories LTD Centerbrook, CT 06409 NDC 10361-793-01

by Bracco Diagnostic Inc

Reason: Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1

by Gilead Sciences, Inc.

Reason: Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

All sterile products within expiry

by Unique Pharmaceutical, Ltd

Reason: Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133

by Unique Pharmaceutical, Ltd

Reason: Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, (present as the hydrochloride), 10 mL cups, Rx only. Manufactured by VistaPharm Inc., Largo, FL 33771. NDC 66689-031-01.

by VistaPharm, Inc.

Reason: Defective Container: Product leaks when inverted.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Metoprolol Succinate Extended-release Tablets, USP 50mg, 90-count Bottles, Rx only, Mfg by Mylan Pharmaceuticals, Inc. Morgantown, WV 26505. NDC 0378-4596-77.

by Mylan Pharmaceuticals Inc.

Reason: Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01

by Astellas Pharma US Inc

Reason: Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA NDC 68382-022-01

by Zydus Pharmaceuticals USA Inc

Reason: Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manufactured by: JOLLC, Gurabo, PR 00778 NDC 50458-578-99

by Janssen Ortho L.L.C.

Reason: Microbial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamination in sales sample.
Published: October 15, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0397-60, UPC 3 05910 39760 9.

by Actavis Laboratories, FL, Inc.

Reason: Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
Published: October 8, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.

by Actavis Laboratories, FL, Inc.

Reason: Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
Published: October 8, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Zoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL), 100 mL single-use bag packaged in a foil overwrap, Rx only, Sterile, For Intravenous Infusion, Mfd. for Sagent Pharmaceuticals Schaumburg, IL ---- NDC 25021-830-82

by Sagent Pharmaceuticals Inc

Reason: Lack of Assurance of Sterility; leaking of premix bags
Published: October 8, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.

by AbbVie Inc

Reason: Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Published: October 8, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, 5000 mL Ambu-Flex II container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Product Code L5B5202, NDC 0941-0457-05.

by Baxter Healthcare Corp.

Reason: Presence of Particulate Matter: particulate matter was found during the manufacturing process.
Published: October 8, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, Baxter USA, NDC 0338-1005-02.

by Baxter Healthcare Corp.

Reason: Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch.
Published: October 8, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 NDC 0409-1560-29

by Hospira Inc.

Reason: Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.
Published: October 8, 2014
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.

by Cubist Pharmaceuticals, Inc.

Reason: Presence of Particulate Matter: Potential presence of glass particulate matter in the vials.
Published: October 8, 2014
Distribution: Nationwide

View recall →

Data last updated: September 28, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.